>
GURUFOCUS.COM > STOCK LIST > Healthcare > Drug Manufacturers > Daiichi Sankyo Co Ltd (TSE:4568) > Definitions > Profitability Rank
Switch to:

Daiichinkyo Co Profitability Rank

: 8 (As of Mar. 2022)
View and export this data going back to 2005. Start your Free Trial

Daiichinkyo Co has the Profitability Rank of 8. It has a higher profitability and may stay that way.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Daiichinkyo Co's Operating Margin % for the quarter that ended in Mar. 2022 was -21.69%. As of today, Daiichinkyo Co's Piotroski F-Score is 7.


Competitive Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Daiichinkyo Co Profitability Rank Distribution

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Profitability Rank falls into.



Daiichinkyo Co Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Daiichinkyo Co has the Profitability Rank of 8. It has a higher profitability and may stay that way.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Daiichinkyo Co's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=-50748 / 233925
=-21.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Good Sign:

Piotroski F-Score is 7, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Daiichinkyo Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Daiichi Sankyo Co Ltd operating margin has been in 5-year decline. The average rate of decline per year is -4.3%.

4. Consistency of the profitability

5. Predictability Rank


Daiichinkyo Co Profitability Rank Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co Business Description

Daiichinkyo Co logo
Industry
Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo Co Ltd is a Japanese pharmaceutical company. It focuses on research and development for bringing up forth novel therapies in oncology, including immune oncology, with further focus on new areas, such as pain management, neurodegenerative diseases, heart and kidney diseases. Daiichi, through the pharmaceutical technology platform, develops processes for manufacturing of quality pharmaceuticals that meet desired efficacy and safety parameters. Daiichi is involved in process technology, biotechnology, formulation technology, analytical and quality evaluation technology. Its products brand includes PRALIA, MOVANTIK, LIXIANA, levofloxacin, Injectafer, and others. The company has its business operations in Europe, North America, and Japan. Most of its revenue comes from Japan.

Daiichinkyo Co Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)